Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 70

1.

Loss of Merlin induces metabolomic adaptation that engages dependence on Hedgehog signaling.

Das S, Jackson WP, Prasain JK, Hanna A, Bailey SK, Tucker JA, Bae S, Wilson LS, Samant RS, Barnes S, Shevde LA.

Sci Rep. 2017 Jan 23;7:40773. doi: 10.1038/srep40773.

2.

BH3 mimetics suppress CXCL12 expression in human malignant peripheral nerve sheath tumor cells.

Graham CD, Kaza N, Pruitt HC, Gibson LM, Klocke BJ, Shevde LA, Carroll SL, Roth KA.

Oncotarget. 2017 Jan 31;8(5):8670-8678. doi: 10.18632/oncotarget.14398.

3.

Genomic regulation of invasion by STAT3 in triple negative breast cancer.

McDaniel JM, Varley KE, Gertz J, Savic DS, Roberts BS, Bailey SK, Shevde LA, Ramaker RC, Lasseigne BN, Kirby MK, Newberry KM, Partridge EC, Jones AL, Boone B, Levy SE, Oliver PG, Sexton KC, Grizzle WE, Forero A, Buchsbaum DJ, Cooper SJ, Myers RM.

Oncotarget. 2017 Jan 31;8(5):8226-8238. doi: 10.18632/oncotarget.14153.

4.

Tamoxifen Induces Cytotoxic Autophagy in Glioblastoma.

Graham CD, Kaza N, Klocke BJ, Gillespie GY, Shevde LA, Carroll SL, Roth KA.

J Neuropathol Exp Neurol. 2016 Oct;75(10):946-954. Epub 2016 Aug 11.

PMID:
27516117
5.

Emerging roles and underlying molecular mechanisms of DNAJB6 in cancer.

Meng E, Shevde LA, Samant RS.

Oncotarget. 2016 Aug 16;7(33):53984-53996. doi: 10.18632/oncotarget.9803. Review.

6.

Erratum to: 'Hedgehog signaling: modulation of cancer properties and tumor microenvironment'.

Hanna A, Shevde LA.

Mol Cancer. 2016 May 11;15(1):35. No abstract available.

7.

Hedgehog signaling: modulation of cancer properies and tumor mircroenvironment.

Hanna A, Shevde LA.

Mol Cancer. 2016 Mar 18;15:24. doi: 10.1186/s12943-016-0509-3. Review. Erratum in: Mol Cancer. 2016;15(1):35.

8.

Loss of tumor suppressor Merlin results in aberrant activation of Wnt/β-catenin signaling in cancer.

Morrow KA, Das S, Meng E, Menezes ME, Bailey SK, Metge BJ, Buchsbaum DJ, Samant RS, Shevde LA.

Oncotarget. 2016 Apr 5;7(14):17991-8005. doi: 10.18632/oncotarget.7494.

9.

Identification of initial leads directed at the calmodulin-binding region on the Src-SH2 domain that exhibit anti-proliferation activity against pancreatic cancer.

Tzou YM, Bailey SK, Yuan K, Shin R, Zhang W, Chen Y, Singh RK, Shevde LA, Krishna NR.

Bioorg Med Chem Lett. 2016 Feb 15;26(4):1237-44. doi: 10.1016/j.bmcl.2016.01.027. Epub 2016 Jan 12.

10.

The Impact of Hedgehog Signaling Pathway on DNA Repair Mechanisms in Human Cancer.

Meng E, Hanna A, Samant RS, Shevde LA.

Cancers (Basel). 2015 Jul 21;7(3):1333-48. doi: 10.3390/cancers7030839. Review.

11.

N-Myc and STAT Interactor regulates autophagy and chemosensitivity in breast cancer cells.

Metge BJ, Mitra A, Chen D, Shevde LA, Samant RS.

Sci Rep. 2015 Jul 6;5:11995. doi: 10.1038/srep11995.

12.

NMI and EMT.

Samant RS, Shevde LA.

Oncoscience. 2014 Jun 19;1(7):476-7. eCollection 2014. No abstract available.

13.

ALDH1A1 maintains ovarian cancer stem cell-like properties by altered regulation of cell cycle checkpoint and DNA repair network signaling.

Meng E, Mitra A, Tripathi K, Finan MA, Scalici J, McClellan S, Madeira da Silva L, Reed E, Shevde LA, Palle K, Rocconi RP.

PLoS One. 2014 Sep 12;9(9):e107142. doi: 10.1371/journal.pone.0107142. eCollection 2014.

14.

microRNA-29 negatively regulates EMT regulator N-myc interactor in breast cancer.

Rostas JW 3rd, Pruitt HC, Metge BJ, Mitra A, Bailey SK, Bae S, Singh KP, Devine DJ, Dyess DL, Richards WO, Tucker JA, Shevde LA, Samant RS.

Mol Cancer. 2014 Aug 29;13:200. doi: 10.1186/1476-4598-13-200.

15.

Role of osteopontin in the pathophysiology of cancer.

Shevde LA, Samant RS.

Matrix Biol. 2014 Jul;37:131-41. doi: 10.1016/j.matbio.2014.03.001. Epub 2014 Mar 19. Review.

16.

GLI1 upregulates C-JUN through a specific 130-kDa isoform.

Amable L, Gavin E, Kudo K, Meng E, Rocconi RP, Shevde LA, Reed E.

Int J Oncol. 2014 Mar;44(3):655-61. doi: 10.3892/ijo.2013.2222. Epub 2013 Dec 20.

17.

Nonclassical hedgehog-GLI signaling and its clinical implications.

Shevde LA, Samant RS.

Int J Cancer. 2014 Jul 1;135(1):1-6. doi: 10.1002/ijc.28424. Epub 2013 Sep 11. Review.

18.

Loss of N-Myc interactor promotes epithelial-mesenchymal transition by activation of TGF-β/SMAD signaling.

Devine DJ, Rostas JW, Metge BJ, Das S, Mulekar MS, Tucker JA, Grizzle WE, Buchsbaum DJ, Shevde LA, Samant RS.

Oncogene. 2014 May 15;33(20):2620-8. doi: 10.1038/onc.2013.215. Epub 2013 Jun 17.

19.

Nonclassical activation of Hedgehog signaling enhances multidrug resistance and makes cancer cells refractory to Smoothened-targeting Hedgehog inhibition.

Das S, Samant RS, Shevde LA.

J Biol Chem. 2013 Apr 26;288(17):11824-33. doi: 10.1074/jbc.M112.432302. Epub 2013 Mar 18.

20.

Cytoplasmic translocation of p21 mediates NUPR1-induced chemoresistance: NUPR1 and p21 in chemoresistance.

Vincent AJ, Ren S, Harris LG, Devine DJ, Samant RS, Fodstad O, Shevde LA.

FEBS Lett. 2012 Sep 21;586(19):3429-34. doi: 10.1016/j.febslet.2012.07.063. Epub 2012 Jul 31.

Supplemental Content

Loading ...
Support Center